References
- 1. Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res. 2012 Jul 11;49(1):35–43.10.1159/00033961322797712
- 2. 21. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008 May 15;453(7193):314–21.10.1038/nature0703918480812
- 3. Sinno H, Prakash S. Complements and the wound healing cascade: an updated review. Plast Surg Int. 2013 Jul 24;2013:146764.10.1155/2013/146764374199323984063
- 4. Pandolfi F, et al. Key role of DAMP in inflammation, cancer, and tissue repair. Clin Ther. 2016;38(5):1017–2810.1016/j.clinthera.2016.02.02827021609
- 5. Venereau E, Ceriotti C, Bianchi ME. DAMPs from Cell Death to New Life. Front Immunol. 2015;6:422.10.3389/fimmu.2015.00422453955426347745
- 6. Muller, S. et al. The double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J. 16, 4337–4340 (2001).
- 7. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191–5.10.1038/nature0085812110890
- 8. Ranzato E, Martinotti S, Pedrazzi M, Patrone M. High mobility group box protein-1 in wound repair. Cells. 2012;1(4):699–710. Published 2012 Sep 28.doi:10.3390/ cells104069910.3390/cells1040699390115324710526
- 9. Straino et al. High-mobility group box 1 protein in human and murine skin: involvement in wound healing. J Invest Dermatol. 2008 Jun;128(6):1545–53. doi: 10.1038/sj.jid.5701212. Epub 2008 Jan 3110.1038/sj.jid.570121218239618
- 10. C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH et al. (2003) Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 101:2652–6010.1182/blood-2002-05-130012456506
- 11. Huang JM, Hu J, Chen N, Hu ML. Relationship between plasma high-mobility group box1 levels and clinical outcomes of ischemic stroke. Journal of critical care. 2013c; 28(5):792–797.10.1016/j.jcrc.2012.10.00323137435
- 12. Yao Y, Su Z, Yang Y, Kao R, Martin CM, Rui T. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK. Am J Physiol Heart Circ Physiol. 2011b; 300(3):H913–H921.10.1152/ajpheart.00703.2010330219421186276
- 13. Peltz ED, Moore EE, Eckels PC, Damle SS, Tsuruta Y, Johnson JL, Sauaia A, Silliman CC, Banerjee A, Abraham E. HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock (Augusta, Ga.). 2009; 32(1):17–22.
- 14. A. Bierhaus, P.M. Humpert, M. Morcos, T. Wendt, T. Chavakis, B. Arnold, D.M. Stern, P.P. Nawroth, Understanding RAGE, the receptor for advanced glycation end products, J. Mol. Med. 83 (2005) 876–88610.1007/s00109-005-0688-716133426
- 15. G.P. Sims, D.C. Rowe, S.T. Rietdijk, R. Herbst, A.J. Coyle, HMGB1 and RAGE in inflammation and cancer, Annu. Rev. Immunol. 28 (2010) 367–388.10.1146/annurev.immunol.021908.13260320192808
- 16. Sorci G, Riuzzi F, Giambanco I, Donato R. RAGE in tissue homeostasis, repair and regeneration. biochim biophys Acta. 2013 Jan;1833(1):101–9.10.1016/j.bbamcr.2012.10.02123103427
- 17. Kim HJ, Jeong MS, Jang SB. Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors. Int J Mol Sci. 2021 Jun 27;22(13):6904.10.3390/ijms22136904826810134199060
- 18. Schmidt AM, Yan SD, Yan SF, Stern DM (2001) The multiligand receptor RAGE is a progression factor amplifying immune and inflammatory responses J Clin Invest 108:949–95510.1172/JCI200114002
- 19. Szczepanski MJ, Luczak M, Olszewska E, Molinska-Glura M, Zagor M, Krzeski A, Skarzynski H, Misiak J, Dzaman K, Bilusiak M, Kopec T, Leszczynska M, Witmanowski H, Whiteside TL. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis. J Mol Med (Berl). 2015 Mar;93(3):305–14.10.1007/s00109-014-1217-3433330125385222
- 20. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.Glycobiology. 2005 Jul;15(7):16R–28R.10.1093/glycob/cwi05315764591
- 21. Ji XY, Chen Y, Ye GH, Dong MW, Lin KZ, Han JG, Feng XP, Li XB, Yu LS, Fan YY. Detection of RAGE expression and its application to diabetic wound age estimation. Int J Legal Med. 2017 May;131(3):691–698.10.1007/s00414-016-1529-728078446
- 22. Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, Lotze MT. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med. 2009 Mar 17;7:17.10.1186/1479-5876-7-17266664219292913
- 23. Rauvala H, Rouhiainen A (2007) RAGE as a receptor of HMGB1 (Amphoterin): roles in health and disease. Curr Mol Med 7:725–73410.2174/15665240778322075018331230
- 24. Kikuchi K, Kawahara KI, Biswas KK, et al. HMGB1: A new marker for estimation of the postmortem interval. Exp Ther Med. 2010;1(1):109–111.10.3892/etm_00000019349037923136602
- 25. Ahmed Alaa El-Din E, Mohamed Ahmed S, Abdallah El Shafei D, El-Sayed Mostafa H. Implication of High-mobility group box-1 and skin post mortem changes in estimation of time passed since death: Animal and human study. Leg Med (Tokyo). 2021 Nov;53:10.1016/j.legalmed.2021.10194934333193
- 26. Gao TL, Yuan XT, Yang D, Dai HL, Wang WJ, Peng X, Shao HJ, Jin ZF, Fu ZJ. Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury. J Trauma Acute Care Surg. 2012 Mar;72(3):643–9.10.1097/TA.0b013e31823c54a622491548
- 27. Li J, Qu X, Schmidt AM. Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J Biol Chem. 1998 Nov 20;273(47):30870–810.1074/jbc.273.47.308709812979